Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0G0TP
|
|||
Former ID |
DNC012177
|
|||
Drug Name |
3-(6-Amino-purin-9-yl)-non-5-yn-2-ol
|
|||
Synonyms |
CHEMBL311182; 3-(6-Amino-purin-9-yl)-non-5-yn-2-ol; BDBM50288071; (2S,3R)-3-(6-Amino-purin-9-yl)-non-5-yn-2-ol
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C14H19N5O
|
|||
Canonical SMILES |
CCCC#CCC(C(C)O)N1C=NC2=C(N=CN=C21)N
|
|||
InChI |
1S/C14H19N5O/c1-3-4-5-6-7-11(10(2)20)19-9-18-12-13(15)16-8-17-14(12)19/h8-11,20H,3-4,7H2,1-2H3,(H2,15,16,17)/t10-,11+/m0/s1
|
|||
InChIKey |
GXOXTRCBYSFJKS-WDEREUQCSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Adenosine deaminase (ADA) | Target Info | Inhibitor | [1] |
BioCyc | Purine nucleotides degradation | |||
Purine deoxyribonucleosides degradation | ||||
Purine ribonucleosides degradation to ribose-1-phosphate | ||||
Adenosine nucleotides degradation | ||||
Superpathway of purine nucleotide salvage | ||||
Adenine and adenosine salvage III | ||||
KEGG Pathway | Purine metabolism | |||
Metabolic pathways | ||||
Primary immunodeficiency | ||||
NetPath Pathway | TCR Signaling Pathway | |||
IL2 Signaling Pathway | ||||
Panther Pathway | Adenine and hypoxanthine salvage pathway | |||
Pathwhiz Pathway | Purine Metabolism | |||
Pathway Interaction Database | p73 transcription factor network | |||
C-MYB transcription factor network | ||||
Validated transcriptional targets of deltaNp63 isoforms | ||||
Validated transcriptional targets of TAp63 isoforms | ||||
Reactome | Purine salvage | |||
WikiPathways | Metabolism of nucleotides |
References | Top | |||
---|---|---|---|---|
REF 1 | Adenosine deaminase inhibitors: synthesis and biological evaluation of unsaturated, aromatic, and oxo derivatives of (+)-erythro-9-(2'S-hydroxy-3'R... J Med Chem. 2000 Nov 30;43(24):4694-700. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.